脂质体输送系统/结核疫苗的辅助剂
Melika Moradi1, Farzaneh Vahedi2, Arian Abbassioun3
1Department of Microbiology, School of Medicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.
Immunity, inflammation and disease
|June 29, 2023
概括
脂质体辅助剂系统显示为结核病 (TB) 疫苗安全有效的输送机制具有前途. 建议进行进一步的临床研究,以优化它们对下一代结核病疫苗的影响.
科学领域:
- 免疫学 免疫学 免疫学
- 疫苗学 疫苗学 疫苗学
- 纳米技术纳米技术
背景情况:
- 结核病 (TB) 仍然是全球卫生危机,每年有数百万人感染并死亡.
- 显著数量的结核病死亡发生在与艾滋病毒同时感染的个体中.
- 开发有效的结核病疫苗对于对抗这种疾病的高感染率和死亡率至关重要.
研究的目的:
- 审查目前结核疫苗辅助剂的研究环境.
- 专门研究脂质体辅助系统在结核病疫苗开发中的潜力.
主要方法:
- 对当前结核病辅助剂研究的文献综述.
- 专注于脂质体辅助系统,分析它们的特性和有效性.
主要成果:
- 脂质体辅助剂系统在纳米到微型尺寸范围内展示了安全性和效率.
- 这些系统适用于针对结核病,其他细胞内感染和恶性瘤的疫苗接种.
- 与传统疫苗相比,结核病的蛋白子单位疫苗显示出更高的保护.
结论:
- 脂质体系统是开发下一代结核病疫苗的有希望的平台.
- 临床研究对于提炼新型结核病辅助剂和最大限度地提高疫苗影响至关重要.
- 辅助剂是提高结核病疫苗在临床试验中的疗效的关键成分.
相关概念视频
Pulmonary Tuberculosis V
214
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
214
Pulmonary Tuberculosis IV
175
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
175
Pulmonary Tuberculosis II
281
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
281


